Antisolvent membrane crystallization of pharmaceutical compounds

Journal of Pharmaceutical Sciences

Volumn 98, Issue 12, 2009, Pages 4902-4913

  Di Profio, Gianluca ^a   Stabile, Carmen ^a   Caridi, Antonella ^a   Curcio, Efrem ^a   Drioli, Enrico ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Antisolvent; Crystal shape; Crystallization; Formulation; Glycine; Membrane; Paracetamol; Pharmaceutical crystallization; Polymorphism; Unit operations

Indexed keywords

GLYCINE; PARACETAMOL; SOLVENT;

ANTISOLVENT MEMBRANE CRYSTALLIZATION; ARTICLE; CRYSTALLIZATION; DRUG SOLUTION;

EID: 71649111893     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21785     Document Type: Article

References (41)

1. Mersmann A. 2001. Crystallization technology handbook. 2nd edition. New York: Marcel Dekker.
2. Mullin JW. 2001. Crystallization. 4th edition. Boston, MA: Butterworth-Heinemann.
3. Myerson AS. 2002. Handbook of industrial crystallization. 2nd edition. Boston, MA: Butterworth-Heinemann.
4. Shekunov BY, York P. 2000. Crystallization processes in pharmaceutical technology and drug delivery design. J Cryst Growth 211:122-136. (Pubitemid 30583697)
5. Fujiwara M, Nagy ZK, Chew JW, Braatz RD. 2005. First-principles and direct design approaches for the control of pharmaceutical crystallization. J Proc Control 15:493-504. (Pubitemid 40206600)
6. Tavare NS. 1995. Industrial crystallization: Process simulation analysis and design. New York: Plenum Press.
7. Yu LX, Lionberger RA, Raw AS, D'Costa R, Wu HQ, Hussain AS. 2004. Applications of process analytical technology to crystallization processes. Adv Drug Deliv Rev 56:349-369. (Pubitemid 38201430)
8. Ansel HC, Allen LV, Popovich NG. 1999. Pharmaceutical dosage forms and drug delivery. 7th edition. Baltimore, MD: Lippincott Williams & Wilkins.
9. Jones AG, Budz J, Mullin JW. 1987. Batch crystallization and solid-liquid separation of potassium sulphate. Chem Eng Sci 42:619-629. (Pubitemid 17565287)
10. Mydlarz J, Jones AG. 1989. Continuous crystallization and subsequent solid-liquid separation of potassium sulphate. Part II: Slurry filterability. Chem Eng Res Des 67:294-300.
11. Tanguy D, Marchal P. 1996. Relations between the properties of particles and their process of manufacture. Chem Eng Res Des 74:715-722. (Pubitemid 126494623)
12. Weingaertner DA, Lynn S, Hanson DN. 1991. Extractive crystallization of salts from concentrated aqueous solution. Ind Eng Chem Res 30:490-501.
13. Oosterhof H, Witkamp GJ, van Rosmalen GM. 1999. Some antisolvents for crystallisation of sodium carbonate. Fluid Phase Equilibria 155:219-227. (Pubitemid 29331857)
14. Chow K, Tong HHY, Lum S, Chow AHL. 2008. Engineering of pharmaceutical materials: An industrial perspective. J Pharm Sci 97:2855-2877.
15. Schöll J, Lindenberg C, Vicum L, Mazzotti M, Brozio J. 2007. Antisolvent precipitation of PDI 747: Kinetics of particle formation and growth. Cryst Growth Des 7:1653-1661.
16. Borissova A, Dashova Z, Lai X, Roberts KJ. 2004. Examination of the semi-batch crystallization of benzophenone from saturated methanol solution via aqueous antisolvent drowning-out as monitored in-process using ATR FTIR spectroscopy. Cryst Growth Des 4:1053-1060. (Pubitemid 39248758)
17. Nowee SM, Abbas A, Romagnoli JA. 2008. Model-based optimal strategies for controlling particle size in antisolvent crystallization operations. Cryst Growth Des 8:2698-2706.
18. Pina CM, Fernandez-Diaz L, Prieto M, Veintemillas-Verdaguer S. 2001. Metastability in drowningout crystallisation: Precipitation of highly soluble sulphates. J Cryst Growth 222:317-327. (Pubitemid 32092273)
19. Alfassi ZB, Mosseri S. 1984. Solventing out of electrolytes from their aqueous solution. AIChE J 30:874-876.
20. Takiyama H, Otsuhata T, Matsuoka M. 1998. Morphology of NaCl crystals in drowning-out precipitation operation. Chem Eng Res Des 76:809-814. (Pubitemid 29149580)
21. Holmbäck X, Rasmuson AC. 1999. Size and morphology of benzoic acid crystals produced by drowning-out crystallization. J Cryst Growth 199:780-788. (Pubitemid 129305757)
22. Barata A, Serrano ML. 1998. Salting-out precipitation of potassium dihydrogen phosphate (KDP): IV. Characterisation of the final product. J Cryst Growth 194:109-118. (Pubitemid 128418239)
23. Kaneko S, Yamagami Y, Tochihara H, Hirasawa I. 2002. Effect of supersaturation on crystal size and number of crystals produced in antisolvent crystallization. J Chem Eng Japan 35:1219-1223. (Pubitemid 36073051)
24. Kitamura M, Sugimoto M. 2003. Anti-solvent crystallization and transformation of thiazole-derivative polymorphs-I: Effect of addition rate and initial concentrations. J Cryst Growth 257:177-184.
25. Beckmann W. 1999. Nucleation phenomena during the crystallisation and precipitation of Abecarnil. J Cryst Growth 199:1307-1314.
26. Yu ZQ, Tan RBH, Chow PS. 2005. Effects of operating conditions on agglomeration and habit of paracetamol crystals in anti-solvent crystallization. J Cryst Growth 279:477-488.
27. Curcio E, Criscuoli A, Drioli E. 2001. Membrane crystallizers. Ind Eng Chem Res 40:2679-2684.
28. Bakker WJW, Geertman RM, Reedijk MF, Baltussen JJM, Bargeman G, van Lare CEJ. Antisolvent solidification process. WO2004/096405A1.
29. Zarkadas DM, Sirkar KK. 2006. Antisolvent crystallization in porous hollow fiber devices. Chem Eng Sci 61:5030-5048. (Pubitemid 43815822)
30. Granberg RA, Rasmuson AC. 1999. Solubility of paracetamol in pure solvents. J Chem Eng Data 44:1391-1395.
31. Bouchard A, Hofland GW, Witkam GJ. 2007. Solubility of glycine polymorphs and recrystallization of β-glycine. J Chem Eng Data 52:1626-1629.
32. Di Profio G, Tucci S, Curcio E, Drioli E. 2007. Selective glycine polymorph crystallization by using microporous membranes. Cryst Growth Des 7:526-530.
33. Di Profio G, Tucci S, Curcio E, Drioli E. 2007. Controlling polymorphism with membrane-based crystallizers: Application to form I and II of paracetamol. Chem Mat 19:2386-2388. (Pubitemid 46834330)
34. Fusaro F, Mazzotti M, Muhrer G. 2004. Gas antisolvent recrystallization of paracetamol from acetone using compressed carbon dioxide as antisolvent. Cryst Growth Des 4:881-889. (Pubitemid 39248742)
35. Rohani S, Horne S, Murthy K. 2005. Control of product quality in batch crystallization of pharmaceuticals and fine chemicals. Part 2: External control. Org Proc Res Devel 9:873-883. (Pubitemid 41524098)
36. Yu ZQ, Chow PS, Tan RBH. 2006. Application of attenuated total reflectance-fourier transform infrared (ATR-FTIR) technique in the monitoring and control of anti-solvent crystallization. Ind Eng Chem Res 45:438-444.
37. Al-Zoubi N, Koundourellis I, Malamataris S. 2002. FT-IR and Raman spectroscopic methods for identification and quantitation of orthorhombic and monoclinic paracetamol in powder mixes. J Pharm Biomed Anal 29:459-467. (Pubitemid 34607806)
38. Nichols G, Frampton CS. 1998. Physicochemical characterization of the orthorhombic polymorph of paracetamol crystallized from solution. J Pharm Sci 87:684-693.
39. Barthe SC, Grover MA, Rousseau RW. 2008. Observation of polymorphic change through analysis of FBRM data: Transformation of paracetamol from form II to form I. Cryst Growth Des 8:3316-3322.
40. Méndez del Rìo JR, Rousseau RW. 2006. Batch and tubular-batch crystallization of paracetamol: Crystal size distribution and polymorph formation. Cryst Growth Des 6:1407-1414.
41. Ulrich J, Strege CJ. 2002. Some aspects of the importance of metastable zone width and nucleation in industrial crystallizers. J Cryst Growth 237-239:2130-2135. (Pubitemid 34545252)